Skip to Content

93 5172 (Alendronate Sodium 35 mg)

Pill with imprint 93 5172 is White, Four-sided and has been identified as Alendronate Sodium 35 mg. It is supplied by Teva Pharmaceuticals USA.

Alendronate is used in the treatment of osteoporosis; prevention of osteoporosis; paget's disease; aseptic necrosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Alendronate 35 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 93 5172

Alendronate sodium 35 mg 93 5172
Alendronate sodium 35 mg 93 5172
Alendronate sodium 35 mg 93 5172

Alendronate Sodium

Imprint:
93 5172
Strength:
35 mg
Color:
White
Size:
7.00 mm
Shape:
Four-sided
Availability:
Prescription only
Drug Class:
Bisphosphonates
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Teva Pharmaceuticals USA
Inactive Ingredients:
croscarmellose sodium
magnesium stearate
microcrystalline cellulose
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
00115-1679 Global Pharmaceuticals

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide